Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry
  • USA - English


News provided by

Boon Edam Inc.

Nov 13, 2018, 10:30 ET

Share this article

Share toX

Share this article

Share toX

Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry
Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry

With the facility storing sensitive clinical data, the Tourlock 180+90 was the perfect fit. Not only does it provide a stronger, more technical security solution for the building, it also allows for higher throughput levels.

Post this

SWANSEA, United Kingdom (PRWEB) November 13, 2018 -- Pharm Research Associates Ltd. is a research center located in the United Kingdom. Founded in 1996, the center conducts commercial, physical and biological research and development. At their Swansea-based facility, Pharm Research Associates determined the need to upgrade the entrance door they had in place, which was no longer fulfilling their needs. Having successfully installed a Boon Edam Crystal TQ revolving door at their Reading head office, the company turned once again to Boon Edam for expert advice on upgrading their Swansea facility.

“The original door had been installed by another entrance provider,” said Neil Simons, National Sales Manager, Boon Edam Limited UK. “Not only was it an older product, it also did not actually serve the true purpose of what our client required.”

Pharmaceutical companies require enhanced levels of security due to the sensitive data stored on site. There is always a critical need to monitor and control who is entering the building, to prevent the risks associated with unauthorized access. Beyond an access control solution to support the company’s high security requirements, there was a need to control the flow of people entering and exiting the building.

The center worked closely with Boon Edam to establish potential threats and ensure the appropriate level of security was incorporated into the new entry solution. It was important for the choice of entrance solution to be correct, not only to meet the building’s requirements, but also to fit with the existing culture.

Boon Edam’s team met with the client to present a range of possibilities and alleviate on-site personnel concerns about the perceived access issues brought on by heightened security measures. After evaluating the range of entry options, the client chose Boon Edam’s automatic Tourlock 180+90 security revolving door with an aluminum finish for its entrance.

“We had worked with Pharm Research Associates on their headquarters in Reading, so we knew the client well and were able to recommend the best solution for their needs,” said Simons. “With the facility storing sensitive clinical data, the Tourlock 180+90 was the perfect fit. Not only does it provide a stronger, more technical security solution for the building, it also allows for higher throughput levels.”

The Tourlock 180+90 prevents unauthorized entry attempts (tailgating and piggybacking), while supporting simultaneous, bi-directional throughput – a level of security that precisely matched the client’s needs.

The project took eight months from confirmation to installation, and despite some bad weather, Boon Edam installed the new door in only four days. Boon Edam also provided a complimentary customer orientation, to inform the management and staff how to properly use and care for the door throughout its lifetime.

For Further Information, Please Contact:
Tracie Thomas, Boon Edam
Vice President of Marketing
T 910 814 8239
E tracie.thomas(at)boonedam.com

For Media Queries, Please Contact:
Sara Chaput, LRG Marketing
Public Relations
T 845 358 1801
E schaput(at)lrgmarketing.com

About Royal Boon Edam
We are proud to be a third generation Dutch family business committed to making people feel welcome and secure through our quality engineered entry solutions. Headquartered in the Netherlands, with a footprint spanning the globe, Royal Boon Edam International is a premium manufacturer of revolving doors, high security doors, turnstiles and Speedlanes. A heritage that exceeds 140 years has resulted in wide expertise in managing the safe transit of people through office buildings, healthcare facilities as well as via public and private spaces. We are truly focused on adding genuine value to our customer’s entrances and to a long-term relationship after sales, service and maintenance. We partner, collaborate and become an extension to the customer team to ensure that the project, people and valuables are in safe hands with us. We are your entry experts. Discover more about our latest news at http://www.boonedam.us/news or follow Boon Edam Inc. on our blog, Facebook, Twitter, and LinkedIn.

Tracie Thomas, Boon Edam Inc., http://www.boonedam.us/, +1 910-814-8239, [email protected]

Modal title

Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry
Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry
Pharm Research Associates Choose Boon Edam Tourlock to Secure their Entry

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.